CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) Short Interest Down 62.5% in June

CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY) was the recipient of a significant decline in short interest in the month of June. As of June 30th, there was short interest totaling 207 shares, a decline of 62.5% from the June 15th total of 552 shares. Based on an average daily trading volume, of 4,625 shares, the short-interest ratio is currently 0.0 days.

CSPC Pharmaceutical Group Price Performance

CSPCY stock remained flat at C$4.18 during trading on Tuesday. The company had a trading volume of 1,484 shares, compared to its average volume of 3,480. The stock has a 50-day moving average of C$3.79 and a 200-day moving average of C$4.41. CSPC Pharmaceutical Group has a 52 week low of C$3.26 and a 52 week high of C$5.83.

About CSPC Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company headquartered in Shijiazhuang, Hebei Province. Established in 1979, the group has grown through organic expansion and strategic acquisitions to become one of the country’s leading manufacturers of active pharmaceutical ingredients (APIs), generic formulations and innovative drug candidates. CSPC is publicly traded in Hong Kong (HKEX: 1093) and maintains American Depositary Receipts on the OTC market (OTCMKTS: CSPCY), reflecting its dual focus on domestic market leadership and international visibility.

The company operates through three primary business segments: bulk pharmaceuticals, finished dosage forms and research-driven products.